Latest news
Tonix Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 16:04:20 GMTTNXP: Tonmya's launch fueled major Q2 revenue growth and pipeline progress, with cash runway into 2027 - tradingview.comtradingview.com · Mon, 10 Aug 2026 14:19:14 GMTTNXP: TONMYA sales nearly tripled in Q2 2026, driving revenue growth and supporting robust pipeline progress - tradingview.comtradingview.com · Mon, 10 Aug 2026 13:32:08 GMTTonix Pharmaceuticals (NASDAQ:TNXP) Announces Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:41:49 GMTIs Tonix Pharmaceuticals (TNXP) Overvalued After Q2 Earnings Rep - GuruFocusGuruFocus · Mon, 10 Aug 2026 12:19:57 GMTTNXP Looks 584.3% Overvalued on GF Value™ - GuruFocusGuruFocus · Mon, 10 Aug 2026 12:19:56 GMTTonix Pharmaceuticals Reports Q2 Revenue of $13.5 Million - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:20:00 GMTTonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:49 GMT